Alastair Greystoke

机构：Newcastle upon Tyne Hospitals NHS Foundation Trust, Sir Bobby Robson Foundation, Newcastle upon Tyne Hospital, Newcastle University · ORCID：0000-0001-9168-0387

发表论文 330 篇 · 总被引 7081 次 · h-index 38

代表论文

• Defactinib with avutometinib in patients with solid tumors: the phase 1 FRAME trial (2025 · Nature Medicine · 被引 31)
• Molecular Tumor Boards: A Consensus Statement From the International Association for the Study of Lung Cancer (2025 · Journal of Thoracic Oncology · 被引 7)
• Routes to Diagnosis in Lung Cancer—Do Socio-Demographics Matter? An English Population-Based Study (2025 · Cancers · 被引 3)
• Real-world frontline treatments in patients with advanced non-small-cell lung cancer harboring epidermal growth factor receptor exon 20 insertions and adjusted comparisons versus amivantamab plus chemotherapy from the PAPILLON study (2025 · Lung Cancer · 被引 3)
• PYNNACLE phase 2 clinical trial of rezatapopt in patients with advanced solid tumors harboring a TP53 Y220C mutation. (2025 · Journal of Clinical Oncology · 被引 2)
• Obrixtamig (BI 764532) in patients (pts) with relapsed/refractory delta-like ligand 3 (DLL3)-high expressing extrapulmonary neuroendocrine carcinoma (epNEC): Dose expansion part of the phase II DAREON-5 trial. (2026 · Journal of Clinical Oncology · 被引 1)